🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalCalgary compounding pharmacies — 12 month update Page 8

Calgary compounding pharmacies — 12 month update

NeuroNate Wed, May 29, 2024 at 11:45 PM 50 replies 2,566 viewsPage 8 of 10
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Jun 6, 2024 at 1:47 AM#36
wendy_avl said:
Practical: whatever you change, write down the date and the reason.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

42 17TrialTracker_MD, JennaRN, LabKate and 39 others
Reply Quote Save Share Report
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Jun 6, 2024 at 9:02 AM#37
wendy_avl said:
Practical: whatever you change, write down the date and the reason.

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

41 16alex_tucson, kevin_tulsa, Dr.PainCLE and 38 others
Reply Quote Save Share Report
paul_denver
Member
723
3,234
May 2024
Denver, CO
Jun 6, 2024 at 4:17 PM#38
wendy_avl said:
Practical: whatever you change, write down the date and the reason.

This is exactly what I could not find anywhere else. Taking it to my next appointment.

Last edited: Jun 6, 2024 at 10:17 PM
40 15wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 37 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Jun 6, 2024 at 11:32 PM#39

From the other side of the consultation, briefly. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

39 14dan_philly, MeganSA_TX, LarryQC_SD and 36 others
Reply Quote Save Share Report
AmyNC_wife
Member
634
2,890
Jun 2024
North Carolina
Jun 7, 2024 at 6:48 AM#40
PharmD_Rodriguez said:
The mechanism and the magnitude are separate questions.

This is my experience too, for whatever a second data point is worth. The detail I would add is minor and it is already implied above.

17 17Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 14 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register